Innovations in Noninvasive Stone Treatment
SonoMotion is developing a noninvasive platform designed to fragment and reposition kidney stones at any clinical setting on fully awake patients.
Breakthrough Device Designation
SonoMotion receives breakthrough device designation from the FDA for its Break Wave device.
SonoMotion Closes Series-C
SonoMotion completes $12 Million Series-C funding round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.
Over 60 Publications in Peer Reviewed Journals
First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones.